PLAP AS TARGET FOR CANCER IMMUNOTHERAPY - DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF BISPECIFIC MONOCLONAL ANTIBODY IN COLORECTAL CANCER IMMUNOTHERAPY

被引：1
|
作者：
Alrishedan, N. S. [1 ]
Bodmer, W. [1 ]
Lastun, V. Liebe [1 ]
Golubovskaya, V. [2 ]
Wu, J. [2 ]
Bransi, A. [3 ]
Umana, P. [3 ]
Klein, C. [3 ]
Seidl, R. Mateus [3 ]
机构：
[1] Univ Oxford, Weatherall Inst Mol Med, Oxford, England
[2] ProMab Biotechnol, Richmond, CA USA
[3] Roche Glycart AG, Schlieren, Switzerland
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-ITOC9.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.01
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 50 条
  • [1] Preclinical development of a monoclonal antibody targeting CD24 as cancer immunotherapy
    Tian, Wenzhi
    Li, Song
    Chen, Dianze
    Liu, Dandan
    Guo, Huiqin
    Yang, Chunmei
    Zhang, Li
    Zhang, Wei
    Tu, Xiaoping
    Peng, Liang
    Zhao, Gui
    Zhang, Ruliang
    Zhang, Fan
    Gan, Frank X.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Bispecific antibody platforms for cancer immunotherapy
    Lameris, Roeland
    de Bruin, Renee C. G.
    Schneiders, Famke L.
    Henegouwen, Paul M. P. van Bergen en
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 92 (03) : 153 - 165
  • [3] Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy
    Zhou, Shu-juan
    Wei, Jia
    Su, Shu
    Chen, Fang-jun
    Qiu, Yu-dong
    Liu, Bao-rui
    JOURNAL OF CANCER, 2017, 8 (18): : 3689 - 3696
  • [4] Review Article Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody
    Moon, Dain
    Tae, Nara
    Park, Yunji
    Lee, Seung-Woo
    Kim, Dae Hee
    IMMUNE NETWORK, 2022, 22 (01)
  • [5] Bispecific antibodies in cancer immunotherapy
    Rader, Christoph
    CURRENT OPINION IN BIOTECHNOLOGY, 2020, 65 : 9 - 16
  • [6] Bispecific antibodies in cancer immunotherapy
    Chen, Siqi
    Li, Jing
    Li, Qing
    Wang, Zhong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (10) : 2491 - 2500
  • [7] Complement System: An Immunotherapy Target in Colorectal Cancer
    Talaat, Iman M.
    Elemam, Noha Mousaad
    Saber-Ayad, Maha
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
    Zheng, Yue
    Fu, Yang
    Wang, Pei-Pei
    Ding, Zhen-Yu
    DISEASE MARKERS, 2022, 2022
  • [9] Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
    W Leconet
    C Larbouret
    T Chardès
    G Thomas
    M Neiveyans
    M Busson
    M Jarlier
    N Radosevic-Robin
    M Pugnière
    F Bernex
    F Penault-Llorca
    J-M Pasquet
    A Pèlegrin
    B Robert
    Oncogene, 2014, 33 : 5405 - 5414
  • [10] Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
    Leconet, W.
    Larbouret, C.
    Chardes, T.
    Thomas, G.
    Neiveyans, M.
    Busson, M.
    Jarlier, M.
    Radosevic-Robin, N.
    Pugniere, M.
    Bernex, F.
    Penault-Llorca, F.
    Pasquet, J-M
    Pelegrin, A.
    Robert, B.
    ONCOGENE, 2014, 33 (47) : 5405 - 5414
12345